ICON plc vs Precision for Medicine

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/iconplc/precision-for-medicine

Category	ICON plc	Precision for Medicine
Listed site	cro	cro
Summary	ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.	Precision for Medicine combines clinical trial management, feasibility and site selection, clinical data management, and biostatistics with specialty lab work in flow cytometry, cytokine proteomics, and biomarker validation. Its cell and gene therapy and companion diagnostic offerings target sponsors developing advanced modalities.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Clinical Imaging Core Lab Central Laboratory Services Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Flow Cytometry Services Bioanalysis Translational Research Biomarker Assays Immunogenicity Assays (ADA / NAb) Ligand-Binding Bioanalysis (Large Molecule) LC-MS Bioanalysis (Small Molecule) Cardiovascular & Metabolic Specialty Services CNS Specialty Services Oncology Specialty Services Immunology & Inflammation Services Companion Diagnostics Development Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy	Clinical Operations Clinical Trial Services Central Laboratory Services Data Management & eClinical Pharmacovigilance & Drug Safety Biostatistics & Statistical Programming Medical Writing Regulatory Affairs Flow Cytometry Services Proteomics Services Genomics & Sequencing Services Bioanalysis Biomarker Assays Translational Research Companion Diagnostics Development
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine	Cell Therapy Gene Therapy AAV / Viral Vector Platform
Indications	Cardiovascular Neurology Immunology Oncology Infectious Disease Metabolic Rare Disease Women's Health Ophthalmology	Data not yet provided.
Locations	Headquarters, Dublin, Ireland Belgium, Belgium, Belgium Bulgaria, Bulgaria, Bulgaria Germany, Germany, Germany Hungary, Hungary, Hungary Italy, Italy, Italy Netherlands, Netherlands, Netherlands Poland, Poland, Poland Romania, Romania, Romania Slovakia, Slovakia, Slovakia South Africa, South Africa, South Africa Spain, Spain, Spain Türkiye, Türkiye, Türkiye United Kingdom, United Kingdom, United Kingdom Australia, Australia, Australia China, China, China India, India, India Japan, Japan, Japan Korea, Korea, Korea Malaysia, Malaysia, Malaysia Taiwan, Taiwan, Taiwan Argentina, Argentina, Argentina Brazil, Brazil, Brazil Chile, Chile, Chile Colombia, Colombia, Colombia Mexico, Mexico, Mexico Belgium, Belgium, Belgium Bulgaria, Bulgaria, Bulgaria Germany, Germany, Germany Hungary, Hungary, Hungary Italy, Italy, Italy Netherlands, Netherlands, Netherlands Poland, Poland, Poland Romania, Romania, Romania Slovakia, Slovakia, Slovakia South Africa, South Africa, South Africa Spain, Spain, Spain Türkiye, Türkiye, Türkiye United Kingdom, United Kingdom, United Kingdom Australia, Australia, Australia China, China, China India, India, India Japan, Japan, Japan Korea, Korea, Korea Malaysia, Malaysia, Malaysia Taiwan, Taiwan, Taiwan Argentina, Argentina, Argentina Brazil, Brazil, Brazil Chile, Chile, Chile Colombia, Colombia, Colombia Mexico, Mexico, Mexico United States, United States, United States	Data not yet provided.
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.